Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like OWC Pharmaceutical Research Corp. Issues Chairman's Letter To Shareholders September 14, 2017 AbbVie Declares Quarterly Dividend February 19, 2017 New Biotech Incubator Just Opened Up in the Big Apple—With Room for 25 Startups June 14, 2017
